Cargando…

Vaccine-induced neutralizing antibodies against SARS-CoV-2 Omicron variant isolated in Osaka, Japan

To study vaccine-induced neutralizing antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants isolated in Osaka, Japan, microneutralization tests were performed on serum samples from 32subjects who received a second dose of vaccination, and 10 of those who received t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hiroi, Satoshi, Morikawa, Saeko, Motomura, Kazushi, Mori, Haruyo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Microbiology Society 2023
Materias:	Short Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996179/ https://www.ncbi.nlm.nih.gov/pubmed/36910512 http://dx.doi.org/10.1099/acmi.0.000465.v3

Ejemplares similares

Resurgence of syphilis in 2022 amongst heterosexual men and women in Osaka, Japan
por: Ukai, Tomohiko, et al.
Publicado: (2023)

Ongoing rubella epidemic in Osaka, Japan, in 2018–2019
por: Kanbayashi, Daiki, et al.
Publicado: (2020)

Infectivity assay for detection of SARS‐CoV‐2 in samples from patients with COVID‐19
por: Hiroi, Satoshi, et al.
Publicado: (2021)

Factors associated with time lag between symptom onset and reporting in the first epidemic wave of COVID-19 in Osaka, Japan
por: Miyama, Takeshi, et al.
Publicado: (2022)

Seasonal shift in epidemics of respiratory syncytial virus infection in Japan
por: Miyama, Takeshi, et al.
Publicado: (2021)

G20 Summit and emergency medical services in Osaka, Japan
por: Tanaka, Kenta, et al.
Publicado: (2021)

Permissive omicron breakthrough infections in individuals with binding or neutralizing antibodies to ancestral SARS-CoV-2
por: Williams, Erin, et al.
Publicado: (2022)

Reduction of influenza in Osaka, Japan during the COVID-19 outbreak: a population-based ORION registry study
por: Hirose, Tomoya, et al.
Publicado: (2021)

SARS-CoV-2 Omicron sublineages show comparable cell entry but differential neutralization by therapeutic antibodies
por: Arora, Prerna, et al.
Publicado: (2022)

Bejel, a Nonvenereal Treponematosis, among Men Who Have Sex with Men, Japan
por: Kawahata, Takuya, et al.
Publicado: (2019)

Clinical efficacy and in vitro neutralization capacity of monoclonal antibodies for severe acute respiratory syndrome coronavirus 2 delta and omicron variants
por: Brehm, Thomas Theo, et al.
Publicado: (2022)

A longitudinal study on respiratory viral infection for healthy volunteers
por: Morikawa, Saeko, et al.
Publicado: (2021)

Increased resistance of SARS-CoV-2 Lambda variant to antibody neutralization
por: Guo, Huimin, et al.
Publicado: (2022)

Isolation of human monoclonal antibodies with neutralizing activity to a broad spectrum of SARS-CoV-2 viruses including the Omicron variants
por: Ueno, Mikako, et al.
Publicado: (2022)

Augmented neutralization of SARS‐CoV‐2 Omicron variant by boost vaccination and monoclonal antibodies
por: Schulz, Sebastian R., et al.
Publicado: (2022)

Potent monoclonal antibodies neutralize Omicron sublineages and other SARS-CoV-2 variants
por: Chen, Zhaochun, et al.
Publicado: (2022)

Neutralizing antibodies and their cocktails against SARS-CoV-2 Omicron and other circulating variants
por: Yang, Yang, et al.
Publicado: (2022)

An RBD bispecific antibody effectively neutralizes a SARS-CoV-2 Omicron variant
por: Yuan, Mengqi, et al.
Publicado: (2023)

Poor neutralizing antibody responses against SARS‐CoV‐2 Omicron BQ.1.1 and XBB in Norway in October 2022
por: Vikse, Elisabeth Lea, et al.
Publicado: (2023)

SARS-CoV-2 omicron BA.1.1 is highly resistant to antibody neutralization of convalescent serum from the origin strain
por: Li, Jianhua, et al.
Publicado: (2023)

Detection of respiratory viruses in gargle specimens of healthy children
por: Morikawa, Saeko, et al.
Publicado: (2015)

Plasma Neutralization of the SARS-CoV-2 Omicron Variant
por: Schmidt, Fabian, et al.
Publicado: (2021)

Neutralization and Stability of SARS-CoV-2 Omicron Variant
por: Zeng, Cong, et al.
Publicado: (2021)

Sensitivity and Specificity of Lung Cancer Screening in Osaka, Japan
por: Sobue, Tomotaka, et al.
Publicado: (1991)

Increase in incidental detection of thyroid cancer in Osaka, Japan
por: Toyoda, Yasuhiro, et al.
Publicado: (2018)

Large-scale serosurveillance of COVID-19 in Japan: Acquisition of neutralizing antibodies for Delta but not for Omicron and requirement of booster vaccination to overcome the Omicron’s outbreak
por: Ren, Zhenxiao, et al.
Publicado: (2022)

Evasion of neutralizing antibody responses by the SARS-CoV-2 BA.2.75 variant
por: Qu, Panke, et al.
Publicado: (2022)

Reduced sensitivity of SARS-CoV-2 Omicron variant to antibody neutralization elicited by booster vaccination
por: Yu, Xiaoqi, et al.
Publicado: (2022)

Broadly neutralizing antibodies against Omicron-included SARS-CoV-2 variants induced by vaccination
por: Chi, Xiangyang, et al.
Publicado: (2022)

Increased resistance of SARS-CoV-2 Omicron variant to neutralization by vaccine-elicited and therapeutic antibodies
por: Tada, Takuya, et al.
Publicado: (2022)

Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant
por: Lyke, Kirsten E., et al.
Publicado: (2022)

Broad-spectrum humanized monoclonal neutralizing antibody against SARS-CoV-2 variants, including the Omicron variant
por: Wen, Kun, et al.
Publicado: (2023)

A spike protein S2 antibody efficiently neutralizes the Omicron variant
por: Hu, Jia, et al.
Publicado: (2022)

Evaluation of cross-neutralizing antibodies in children infected with omicron sub-variants
por: Peng, Weiyu, et al.
Publicado: (2023)

SARS-CoV-2 omicron variant: the black swan of microbiology
por: Cheng, Zhangkai J., et al.
Publicado: (2022)

Omicron‐specific mRNA vaccine induced cross‐protective immunity against ancestral SARS‐CoV‐2 infection with low neutralizing antibodies
por: Shen, Kuan‐Yin, et al.
Publicado: (2022)

Plasma neutralization properties of the SARS-CoV-2 Omicron variant
por: Schmidt, Fabian, et al.
Publicado: (2021)

Immune evasion of neutralizing antibodies by SARS-CoV-2 Omicron
por: Wang, Lidong, et al.
Publicado: (2023)

Factors associated with prolonged duration of viral clearance in non-severe SARS-CoV-2 patients in Osaka, Japan
por: Hoffman, Emma Nakagawa, et al.
Publicado: (2021)

35B5 antibody potently neutralizes SARS-CoV-2 Omicron by disrupting the N-glycan switch via a conserved spike epitope
por: Wang, Xiaofei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3nde2v1u08mpv1m8djgc4eg9t0